Aripiprazole orally disintegrating

FDA Drug Profile — Aripiprazole

Aripiprazole orally disintegrating is listed in the FDA National Drug Code directory with 6 NDC codes, marketed under brand name including Aripiprazole. Available dosage form: tablet.

Drug details

Generic Name
Aripiprazole orally disintegrating
Brand Names
Aripiprazole
Application Number
ANDA207240
Sponsor
ScieGen Pharmaceuticals Inc
NDC Codes
6
Dosage Forms
TABLET
Routes
ORAL
Active Ingredients
ARIPIPRAZOLE

Indications and Usage

1 INDICATIONS AND USAGE Aripiprazole orally disintegrating tablets are indicated for the treatment of: Schizophrenia [see Clinical Studies (14.1) ] Irritability Associated with Autistic Disorder [see Clinical Studies (14.4) ] Treatment of Tourette’s Disorder [see Clinical Studies (14.5) ] Aripiprazole is an atypical antipsychotic. The oral formulation is indicated for: Schizophrenia ( 14.1 ) Irritability Associated with Autistic Disorder ( 14.4 ) Treatment of Tourette’s disorder ( 14.5 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.